CBD Solutions   Report issue

For profit Phase 1
Founded: London United Kingdom (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2014
NCT02133846
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

tpi-287 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Supranuclear Palsy, Progressive (Phase 1)

Syndrome (Phase 1)

Tauopathies (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1